Michael Gelband’s Pulmatrix PULM Stock Holding History

Michael Gelband’s Portfolio PULM Stock Details PULM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-730	Closed	-$15K	–	2526
2021 Q2	$15K	Buy	+730	New	+$14.8K	﹤0.01%	2258

Other funds holding PULM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Michael Gelband's PULM Position: Q3 2021 in Review

Michael Gelband sold out of Pulmatrix (PULM) in Q3 2021, closing a stake of 730 shares — an estimated $15K sold.

Michael Gelband first reported a position in PULM in Q2 2021 and held it in 1 quarter. The position peaked at $15K in Q2 2021. 20 funds tracked by Wall St. Rank hold PULM as of Q3 2021.

Michael Gelband reported no remaining Pulmatrix position as of Q3 2021 after selling out during the quarter.
Michael Gelband sold 730 Pulmatrix shares in Q3 2021, an estimated $15K.
Michael Gelband first reported a position in Pulmatrix in Q2 2021 and held it in 1 quarter.
Michael Gelband's Pulmatrix position peaked at $15K in Q2 2021.
20 funds tracked by Wall St. Rank held Pulmatrix as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.